Oslo, 25 March 2026.
With reference to today's webcast, please find enclosed the presentation.
Key topics:
- 80% growth in quarterly sales LTM
- Commercial launch of UnoMeter(TM) Safeti Max
- Extended product offering to our distributors, capitalizing on the UnoMeter brand position
- Sales in 46 countries
- Current addressable market value grown from NOK ~670m to ~2.6bn
A recording of the presentation is also available at:https://qcnl.tv/p/OLaQ0Xa8KdjTtD9W3cv0PQ
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: [email protected]
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: [email protected]
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.
https://news.cision.com/observe-medical-asa/r/observe-medical---company-presentation-with-trading-update,c4326359
https://mb.cision.com/Main/19175/4326359/4004588.pdf
(c) 2026 Cision. All rights reserved., source Press Releases - English